Comparative pharmacokinetics and pharmacodynamics of amikacin and ceftazidime in tricuspid and aortic vegetations in experimental Pseudomonas endocarditis
- PMID: 3042875
- DOI: 10.1093/infdis/158.2.355
Comparative pharmacokinetics and pharmacodynamics of amikacin and ceftazidime in tricuspid and aortic vegetations in experimental Pseudomonas endocarditis
Abstract
A factor in the higher medical cure rates for endocarditis in the right as opposed to the left side of the heart in humans may be a difference in antimicrobial pharmacokinetics within vegetations. Rabbits with combined tricuspid and aortic endocarditis due to Pseudomonas aeruginosa received single intravenous doses of either ceftazidime (50 mg/kg) or amikacin (15 or 40 mg/kg). For each antibiotic regimen, areas under the time-concentration curves and percent vegetation penetrances were significantly greater for tricuspid than aortic vegetations (P less than .001). Time-concentration curves for aortic vegetations paralleled those for plasma; curves for the tricuspid vegetations resembled those for subcutaneous fibrin clots. The times above the minimum bactericidal concentration for tricuspid vegetations were significantly longer than those achieved within aortic vegetations for ceftazidime (P less than .01) and amikacin at 15 mg/kg (P less than .001). Antimicrobial pharmacokinetics and pharmacodynamics may be more favorable within tricuspid than aortic vegetations; this difference may, in part, explain more salutary outcomes in bacterial endocarditis involving the right side of the heart.
Similar articles
-
Efficacy of amikacin and ceftazidime in experimental aortic valve endocarditis due to Pseudomonas aeruginosa.Antimicrob Agents Chemother. 1985 Dec;28(6):781-5. doi: 10.1128/AAC.28.6.781. Antimicrob Agents Chemother. 1985. PMID: 3909954 Free PMC article.
-
Intravegetation antimicrobial distribution in aortic endocarditis analyzed by computer-generated model. Implications for treatment.Chest. 1990 Mar;97(3):611-7. doi: 10.1378/chest.97.3.611. Chest. 1990. PMID: 2106410
-
Amikacin + ceftazidime therapy of experimental right-sided Pseudomonas aeruginosa endocarditis in rabbits.Chemotherapy. 1985;31(5):351-61. doi: 10.1159/000238359. Chemotherapy. 1985. PMID: 3931992
-
Endovascular infections arising from right-sided heart structures.Cardiol Clin. 1992 Feb;10(1):137-49. Cardiol Clin. 1992. PMID: 1739955 Review.
-
[A successful repair of acquired left ventricular-right atrial communication due to infective endocarditis].Nihon Kyobu Geka Gakkai Zasshi. 1994 Aug;42(8):1193-7. Nihon Kyobu Geka Gakkai Zasshi. 1994. PMID: 7963835 Review. Japanese.
Cited by
-
Failure of treatment with teicoplanin at 6 milligrams/kilogram/day in patients with Staphylococcus aureus intravascular infection. The Infectious Diseases Consortium of Oregon.Antimicrob Agents Chemother. 1991 Jan;35(1):79-87. doi: 10.1128/AAC.35.1.79. Antimicrob Agents Chemother. 1991. PMID: 1826594 Free PMC article. Clinical Trial.
-
Prediction of tissue exposures of polymyxin-B, amikacin and sulbactam using physiologically-based pharmacokinetic modeling.Front Microbiol. 2024 Oct 7;15:1435906. doi: 10.3389/fmicb.2024.1435906. eCollection 2024. Front Microbiol. 2024. PMID: 39435440 Free PMC article.
-
Treatment of experimental staphylococcal endocarditis due to a strain with reduced susceptibility in vitro to vancomycin: efficacy of ampicillin-sulbactam.Antimicrob Agents Chemother. 1999 Oct;43(10):2565-8. doi: 10.1128/AAC.43.10.2565. Antimicrob Agents Chemother. 1999. PMID: 10508047 Free PMC article.
-
Efficacy of ceftazidime and aztreonam alone or in combination with amikacin in experimental left-sided Pseudomonas aeruginosa endocarditis.Antimicrob Agents Chemother. 1993 Feb;37(2):308-13. doi: 10.1128/AAC.37.2.308. Antimicrob Agents Chemother. 1993. PMID: 8452362 Free PMC article.
-
Efficacy of trovafloxacin, a new quinolone antibiotic, in experimental staphylococcal endocarditis due to oxacillin-resistant strains.Antimicrob Agents Chemother. 1998 Jul;42(7):1837-41. doi: 10.1128/AAC.42.7.1837. Antimicrob Agents Chemother. 1998. PMID: 9661030 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources